ALT
Altimmune Inc
3.00$
-4.7%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 91.8% | 99.5% | 99.6% | 98.8% | 98.6% | 98.5% | 98.7% | 99.0% | 99.2% | 99.4% | 99.7% | 63.5% | |
| 52.1% | 64.1% | 41.9% | 33.0% | 21.3% | 26.5% | 31.2% | 96.2% | 28.0% | 15.6% | 29.1% | 12.0% | |
| 84.5% | 93.9% | 96.6% | 95.1% | 94.3% | 94.7% | 95.3% | 96.2% | 96.5% | 97.7% | 98.8% | 61.9% | |
| 2.7% | 2.3% | 1.4% | 1.7% | 2.3% | 2.2% | 1.6% | 0.5% | 0.1% | 0.6% | 0.1% | 0.6% | |
| 0.0% | – | 0.0% | – | 0.0% | – | – | – | – | – | – | – | |
| 0.7% | – | – | – | – | – | – | – | – | – | – | – | |
| 7.5% | – | – | – | – | – | – | – | – | – | – | – | |
| 9.7% | 7.9% | 8.2% | 12.0% | 9.8% | 11.3% | 9.6% | 15.2% | 15.0% | 19.7% | 15.4% | 10.1% | |
| 7.1% | 5.8% | 6.0% | 8.7% | 5.8% | 7.5% | 6.2% | 4.8% | 5.8% | 5.4% | 3.4% | 2.4% | |
| 0.3% | 0.2% | 0.3% | 0.2% | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% | 0.1% | 0.1% | – | |
| 1.8% | 1.0% | 2.0% | 1.6% | 0.8% | 0.2% | 0.7% | 0.4% | 2.2% | 1.0% | 0.5% | 0.2% | |
| – | – | – | – | – | – | – | 7.5% | 6.6% | 12.2% | 10.3% | 6.6% | |
| 90.3% | 92.1% | 91.8% | 88.0% | 90.2% | 88.7% | 90.4% | 84.8% | 85.0% | 80.3% | 84.6% | 89.9% | |
| -261.0% | -221.4% | -260.5% | -297.3% | -364.0% | -403.0% | -369.4% | -316.8% | -284.8% | -232.0% | -200.2% | -131.8% | |
| 32.2% | 27.7% | 37.6% | 40.9% | 48.1% | 51.2% | 48.0% | 42.8% | 40.9% | 35.9% | 37.1% | 35.2% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.